在甲状腺癌中通过视网膜-OPN3复合体进行蓝光驱动的细胞循环停止
Changrui Zhao1, Jiaqiang Bo1, Tianyu Li1
1Department of Endocrinology, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, China.
Cell communication and signaling : CCS
|November 2, 2024
概括
使用蓝光的光生物调制疗法 (PBMT) 在治疗乳头甲状腺癌 (PTC) 方面显示出前景. 这种非侵入性方法调节视网膜-OPN3复合体,抑制癌细胞增殖,并提供了一种新的治疗途径.
科学领域:
- 生物光子学 生物光子学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 乳头甲状腺癌 (PTC) 是最常见的甲状腺恶性瘤,发病率越来越高.
- 传统的治疗方法,如手术和放射治疗,会引起显著的副作用,需要新的治疗策略.
- 对于PTC管理而言,非常需要非侵入性治疗方法.
研究的目的:
- 调查蓝光光生物调节疗法 (PBMT) 作为乳头甲状腺癌 (PTC) 的非侵入性治疗方法的疗效.
- 探索视网膜-OPSIN 3 (OPN3) 综合体在中介PTC细胞中对PBMT的细胞反应中的作用.
主要方法:
- PTC细胞暴露在蓝光下.
- 对细胞增殖,细胞循环进展和蛋白质表达的分析.
- 使用统计分析调查视网膜-OPSIN 3 (OPN3) 综合体的参与.
主要成果:
- 蓝光暴露导致11-cis-视网膜与OPN3分离,导致全跨视网膜积累.
- 这种分子变化破坏了PTC细胞的增殖,并诱导了G0/G1细胞周期停止.
- 视网膜-OPN3复合体被确定为一个关键的媒介,证实了甲状腺细胞光感受潜力.
结论:
- 针对视网膜-OPN3复合体的PBMT为PTC提供了一个有希望的非侵入性治疗选择.
- 这项研究强调了光信号传导在非眼组织中用于癌症治疗的潜力.
- 这项研究为开发非侵入性癌症治疗开辟了新的途径.
相关概念视频
Photoreceptors and Visual Pathways
5.7K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.7K
Synthesis and Regulation of Thyroid Hormones
4.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.2K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K


